SCHEMBL2240798

SCHEMBL2240798

CC(=Cc1ccc(C)cc1)CCC=O

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.43
RAB9A P51151 2/20 0.41
KMT2A Q03164 2/20 0.41
HPGD P15428 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
PTGS2 P35354 1/20 0.37
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
FBP1 P09467 1/20 0.35
RARB P10826 2/20 0.35
RARG P13631 2/20 0.35
RARA P10276 1/20 0.35
RXRA P19793 1/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2240794 1.00 CYP2A6 (0.43) CYP2A6RAB9AKMT2AHPGDTRPV1
SCHEMBL2243080 1.00 CYP2A6 (0.43) CYP2A6RAB9AKMT2AHPGDTRPV1
SCHEMBL2238734 0.83 TSHR (0.52) KMT2AHPGDFBP1LMNA
SCHEMBL2238736 0.83 TSHR (0.52) KMT2AHPGDFBP1LMNA
SCHEMBL31380615 0.82 HPGD (0.42) RAB9AKMT2AHPGDPTGS2MAPT
SCHEMBL31380606 0.82 HPGD (0.42) RAB9AKMT2AHPGDPTGS2MAPT
SCHEMBL31380618 0.82 HPGD (0.42) RAB9AKMT2AHPGDPTGS2MAPT
SCHEMBL3360105 0.81 KMT2A (0.57) RAB9AKMT2AMAPTNPC1POLB
SCHEMBL3360111 0.81 KMT2A (0.57) RAB9AKMT2AMAPTNPC1POLB
SCHEMBL31380624 0.81 ALDH1A1 (0.48) CYP2A6RAB9AKMT2AHPGDTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608360-A1 ANTI-DANDRUFF COMPOSITIONS Firmenich SA (CH) 2025-09-03 EP claimed
US-20250134790-A1 ANTIMICROBIAL COMPOSITIONS FIRMENICH SA (CH) 2025-05-01 US claimed
EP-4519404-A1 METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN Firmenich SA (CH) 2025-03-12 EP claimed
EP-4514477-A1 FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE Firmenich SA (CH) 2025-03-05 EP claimed
US-20240390246-A1 IMPROVED PERFUME COMPOSITIONS COMPRISING SULFUR-CONTAINING PRO-FRAGRANCE COMPOUNDS FIRMENICH SA (CH) 2024-11-28 US claimed
WO-2024133645-A1 ANTI-DANDRUFF COMPOSITIONS FIRMENICH SA (CH) 2024-06-27 WO claimed
EP-4387583-A1 ANTIMICROBIAL COMPOSITIONS Firmenich SA (CH) 2024-06-26 EP claimed
EP-4376799-A1 IMPROVED PERFUME COMPOSITIONS COMPRISING SULFUR-CONTAINING PRO-FRAGRANCE COMPOUNDS Firmenich SA (CH) 2024-06-05 EP claimed
CN-117999057-A Improved perfume compositions comprising sulfur-containing fragrance precursor compounds 弗门尼舍有限公司 2024-05-07 CN claimed
CN-117881386-A Antimicrobial compositions 弗门尼舍有限公司 2024-04-12 CN claimed
WO-2022129351-A1 A SYNERGISTIC PERFUMING COMPOSITION FIRMENICH SA (CH) 2022-06-23 WO claimed
CN-110099993-B High impact perfume microcapsules of balanced density 弗门尼舍有限公司 2021-08-24 CN claimed
US-10918579-B2 Density balanced high impact perfume microcapsules FIRMENICH SA (CH) 2021-02-16 US claimed
US-9487734-B2 Perfuming ingredients of the floral and/or anis type FIRMENICH SA (CH) 2016-11-08 US claimed
US-20140314699-A1 PERFUMING INGREDIENTS OF THE FLORAL AND/OR ANIS TYPE FIRMENICH SA (CH) 2014-10-23 US claimed
US-8815792-B2 Perfuming ingredients of the floral and/or anis type FIRMENICH SA (CH) 2014-08-26 US claimed
EP-2352809-B1 PERFUMING INGREDIENTS OF THE FLORAL AND/OR ANIS TYPE FIRMENICH & CIE (CH) 2012-09-19 EP claimed
US-20110200546-A1 PERFUMING INGREDIENTS OF THE FLORAL AND/OR ANIS TYPE FIRMENICH SA (CH) 2011-08-18 US claimed
EP-2352809-A1 PERFUMING INGREDIENTS OF THE FLORAL AND/OR ANIS TYPE Firmenich S.A. (CH) 2011-08-10 EP claimed
WO-2010052635-A1 PERFUMING INGREDIENTS OF THE FLORAL AND/OR ANIS TYPE FIRMENICH SA (CH) 2010-05-14 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200546-A1 PERFUMING INGREDIENTS OF THE FLORAL AND/OR ANIS TYPE COXFA4, CCR4, AFF4 CYP2A6 2508/4885RAB9A 3963/4885KMT2A 2491/4885
US-20240390246-A1 IMPROVED PERFUME COMPOSITIONS COMPRISING SULFUR-CONTAINING PRO-FRAGRANCE COMPOUNDS PHGDH, SORD, CTH CYP2A6 2472/4885RAB9A 3888/4885KMT2A 3924/4885
US-20140314699-A1 PERFUMING INGREDIENTS OF THE FLORAL AND/OR ANIS TYPE COXFA4, CCR4, AFF4 CYP2A6 2508/4885RAB9A 3963/4885KMT2A 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.